Q2 Earnings Forecast for CCRN Issued By Barrington Research

Cross Country Healthcare, Inc. (NASDAQ:CCRN) – Analysts at Barrington Research dropped their Q2 2025 earnings per share estimates for shares of Cross Country Healthcare in a research note issued to investors on Tuesday, June 17th. Barrington Research analyst K. Steinke now expects that the business services provider will post earnings per share of $0.04 for the quarter, down from their prior forecast of $0.09. Barrington Research currently has a “Market Perform” rating and a $18.61 price target on the stock. The consensus estimate for Cross Country Healthcare’s current full-year earnings is $0.53 per share. Barrington Research also issued estimates for Cross Country Healthcare’s Q3 2025 earnings at $0.06 EPS, Q4 2025 earnings at $0.09 EPS and FY2025 earnings at $0.26 EPS.

CCRN has been the topic of several other reports. Wall Street Zen assumed coverage on shares of Cross Country Healthcare in a research note on Thursday, May 15th. They set a “hold” rating on the stock. UBS Group dropped their price target on Cross Country Healthcare from $18.61 to $16.50 and set a “neutral” rating on the stock in a research report on Tuesday, May 13th. Seven investment analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $17.93.

Cross Country Healthcare Stock Performance

Shares of NASDAQ:CCRN opened at $14.25 on Thursday. The firm has a 50 day simple moving average of $13.70 and a 200 day simple moving average of $15.88. Cross Country Healthcare has a 52 week low of $9.58 and a 52 week high of $18.50. The company has a market cap of $467.12 million, a PE ratio of -26.89, a price-to-earnings-growth ratio of 4.08 and a beta of 0.37.

Cross Country Healthcare (NASDAQ:CCRN) last announced its earnings results on Wednesday, May 7th. The business services provider reported $0.06 EPS for the quarter, topping the consensus estimate of $0.04 by $0.02. Cross Country Healthcare had a negative net margin of 1.41% and a positive return on equity of 2.56%. The business’s quarterly revenue was down 22.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.19 earnings per share.

Hedge Funds Weigh In On Cross Country Healthcare

Several institutional investors and hedge funds have recently modified their holdings of the stock. Quadrant Capital Group LLC acquired a new stake in Cross Country Healthcare during the fourth quarter valued at $25,000. Plato Investment Management Ltd acquired a new position in Cross Country Healthcare in the fourth quarter worth approximately $46,000. Longfellow Investment Management Co. LLC bought a new position in Cross Country Healthcare during the first quarter valued at approximately $59,000. AlphaQuest LLC boosted its holdings in Cross Country Healthcare by 324.6% in the first quarter. AlphaQuest LLC now owns 8,297 shares of the business services provider’s stock worth $124,000 after purchasing an additional 6,343 shares in the last quarter. Finally, Mint Tower Capital Management B.V. acquired a new stake in shares of Cross Country Healthcare in the fourth quarter worth about $182,000. 96.03% of the stock is currently owned by hedge funds and other institutional investors.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.